138 related articles for article (PubMed ID: 18472002)
1. Arginine methylation of hnRNP K enhances p53 transcriptional activity.
Chen Y; Zhou X; Liu N; Wang C; Zhang L; Mo W; Hu G
FEBS Lett; 2008 May; 582(12):1761-5. PubMed ID: 18472002
[TBL] [Abstract][Full Text] [Related]
2. hnRNP K: an HDM2 target and transcriptional coactivator of p53 in response to DNA damage.
Moumen A; Masterson P; O'Connor MJ; Jackson SP
Cell; 2005 Dec; 123(6):1065-78. PubMed ID: 16360036
[TBL] [Abstract][Full Text] [Related]
3. Methylation-acetylation interplay activates p53 in response to DNA damage.
Ivanov GS; Ivanova T; Kurash J; Ivanov A; Chuikov S; Gizatullin F; Herrera-Medina EM; Rauscher F; Reinberg D; Barlev NA
Mol Cell Biol; 2007 Oct; 27(19):6756-69. PubMed ID: 17646389
[TBL] [Abstract][Full Text] [Related]
4. The importance of heterogeneous nuclear ribonucleoprotein K on cytochrome P450 2D2 gene regulation: its binding is reduced in Dark Agouti rats.
Sakai N; Sakamoto KQ; Fujita S; Ishizuka M
Drug Metab Dispos; 2009 Aug; 37(8):1703-10. PubMed ID: 19420131
[TBL] [Abstract][Full Text] [Related]
5. Expression levels of hnRNP K and p21WAF1/CIP1 are associated with resistance to radiochemotherapy independent of p53 pathway activation in rectal adenocarcinoma.
Daskalaki W; Wardelmann E; Port M; Stock K; Steinestel J; Huss S; Sperveslage J; Steinestel K; Eder S
Int J Mol Med; 2018 Dec; 42(6):3269-3277. PubMed ID: 30272263
[TBL] [Abstract][Full Text] [Related]
6. The transactivation domain of heterogeneous nuclear ribonucleoprotein K overlaps its nuclear shuttling domain.
Chan JY; Huang SM; Liu ST; Huang CH
Int J Biochem Cell Biol; 2008; 40(10):2078-89. PubMed ID: 18346927
[TBL] [Abstract][Full Text] [Related]
7. Identification of the methylation preference region in heterogeneous nuclear ribonucleoprotein K by protein arginine methyltransferase 1 and its implication in regulating nuclear/cytoplasmic distribution.
Chang YI; Hsu SC; Chau GY; Huang CY; Sung JS; Hua WK; Lin WJ
Biochem Biophys Res Commun; 2011 Jan; 404(3):865-9. PubMed ID: 21184736
[TBL] [Abstract][Full Text] [Related]
8. Functional interaction of Sam68 and heterogeneous nuclear ribonucleoprotein K.
Yang JP; Reddy TR; Truong KT; Suhasini M; Wong-Staal F
Oncogene; 2002 Oct; 21(47):7187-94. PubMed ID: 12370808
[TBL] [Abstract][Full Text] [Related]
9. SUMOylation of hnRNP-K is required for p53-mediated cell-cycle arrest in response to DNA damage.
Lee SW; Lee MH; Park JH; Kang SH; Yoo HM; Ka SH; Oh YM; Jeon YJ; Chung CH
EMBO J; 2012 Nov; 31(23):4441-52. PubMed ID: 23092970
[TBL] [Abstract][Full Text] [Related]
10. Interaction of heterogeneous nuclear ribonucleoprotein C1/C2 with a novel cis-regulatory element within p53 mRNA as a response to cytostatic drug treatment.
Christian KJ; Lang MA; Raffalli-Mathieu F
Mol Pharmacol; 2008 May; 73(5):1558-67. PubMed ID: 18296503
[TBL] [Abstract][Full Text] [Related]
11. Biophysical and biochemical analysis of hnRNP K: arginine methylation, reversible aggregation and combinatorial binding to nucleic acids.
Moritz B; Lilie H; Naarmann-de Vries IS; Urlaub H; Wahle E; Ostareck-Lederer A; Ostareck DH
Biol Chem; 2014 Jul; 395(7-8):837-53. PubMed ID: 25003387
[TBL] [Abstract][Full Text] [Related]
12. hnRNP K suppresses apoptosis independent of p53 status by maintaining high levels of endogenous caspase inhibitors.
Xiao Z; Ko HL; Goh EH; Wang B; Ren EC
Carcinogenesis; 2013 Jul; 34(7):1458-67. PubMed ID: 23455382
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells.
Liu PY; Chan JY; Lin HC; Wang SL; Liu ST; Ho CL; Chang LC; Huang SM
Mol Cancer Res; 2008 Jul; 6(7):1204-14. PubMed ID: 18644983
[TBL] [Abstract][Full Text] [Related]
14. hnRNP K interacts with RNA binding motif protein 42 and functions in the maintenance of cellular ATP level during stress conditions.
Fukuda T; Naiki T; Saito M; Irie K
Genes Cells; 2009 Feb; 14(2):113-28. PubMed ID: 19170760
[TBL] [Abstract][Full Text] [Related]
15. Asymmetric arginine dimethylation of heterogeneous nuclear ribonucleoprotein K by protein-arginine methyltransferase 1 inhibits its interaction with c-Src.
Ostareck-Lederer A; Ostareck DH; Rucknagel KP; Schierhorn A; Moritz B; Huttelmaier S; Flach N; Handoko L; Wahle E
J Biol Chem; 2006 Apr; 281(16):11115-25. PubMed ID: 16492668
[TBL] [Abstract][Full Text] [Related]
16. MDM2-dependent downregulation of p21 and hnRNP K provides a switch between apoptosis and growth arrest induced by pharmacologically activated p53.
Enge M; Bao W; Hedström E; Jackson SP; Moumen A; Selivanova G
Cancer Cell; 2009 Mar; 15(3):171-83. PubMed ID: 19249676
[TBL] [Abstract][Full Text] [Related]
17. The interaction of the hnRNP family member E1B-AP5 with p53.
Barral PM; Rusch A; Turnell AS; Gallimore PH; Byrd PJ; Dobner T; Grand RJ
FEBS Lett; 2005 May; 579(13):2752-8. PubMed ID: 15907477
[TBL] [Abstract][Full Text] [Related]
18. Direct mass-spectrometric identification of Arg296 and Arg299 as the methylation sites of hnRNP K protein for methyltransferase PRMT1.
Chiou YY; Lin WJ; Fu SL; Lin CH
Protein J; 2007 Feb; 26(2):87-93. PubMed ID: 17191129
[TBL] [Abstract][Full Text] [Related]
19. Compartmentalization of hnRNP-K during cell cycle progression and its interaction with calponin in the cytoplasm.
Laury-Kleintop LD; Tresini M; Hammond O
J Cell Biochem; 2005 Aug; 95(5):1042-56. PubMed ID: 15962305
[TBL] [Abstract][Full Text] [Related]
20. Physical and functional interactions between hnRNP K and PRMT family proteins.
Chan JY; Hsieh TY; Liu ST; Chou WY; Chung MH; Huang SM
FEBS Lett; 2009 Jan; 583(2):281-6. PubMed ID: 19101556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
